Aaron C. Logan

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 769 citations · Full text

Medicine, Hematology, Oncology +9

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy

David B. Miklos, Corey Cutler, Mukta Arora et al. · Blood · 2017 · 499 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia

Christine M. McMahon, Timothy T. Ferng, Jonathan Canaani et al. · Cancer Discovery · 2019 · 437 citations · Full text

Medicine, Oncology, Pharmacology +16

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Corey Cutler, Stephanie J. Lee, Sally Arai et al. · Blood · 2021 · 327 citations · Full text

Life Sciences, Immunology, Surgery +9

Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Patrick A. Brown, Bijal Shah, Anjali S. Advani et al. · Journal of the National Comprehensive Cancer Network · 2021 · 241 citations · Full text

Medicine, Oncology, Pediatrics +17